{"id":"https://openalex.org/W2036006754","doi":"https://doi.org/10.1016/j.aller.2012.04.006","title":"Injection site reaction to adalimumab: Positive skin test and successful rapid desensitisation","display_name":"Injection site reaction to adalimumab: Positive skin test and successful rapid desensitisation","publication_year":2012,"publication_date":"2012-10-10","ids":{"openalex":"https://openalex.org/W2036006754","doi":"https://doi.org/10.1016/j.aller.2012.04.006","mag":"2036006754","pmid":"https://pubmed.ncbi.nlm.nih.gov/23063342"},"language":"en","primary_location":{"id":"doi:10.1016/j.aller.2012.04.006","doi":"https://doi.org/10.1016/j.aller.2012.04.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.aller.2012.04.006","pdf_url":null,"source":{"id":"https://openalex.org/S4210205432","display_name":"Allergologia et Immunopathologia","issn_l":"0301-0546","issn":["0301-0546","1578-1267"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","latindex","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergologia et Immunopathologia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.aller.2012.04.006","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054370889","display_name":"Sevim Bavbek","orcid":"https://orcid.org/0000-0002-7884-0830","observed_orcids":["https://orcid.org/0000-0002-7884-0830"]},"institutions":[{"id":"https://openalex.org/I149218525","display_name":"Ankara University","ror":"https://ror.org/01wntqw50","country_code":"TR","type":"education","lineage":["https://openalex.org/I149218525"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"S. Bavbek","raw_affiliation_strings":["Ankara University, School of Medicine, Department of Pulmonary Disease, Division of Immunology and Allergy, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ankara University, School of Medicine, Department of Pulmonary Disease, Division of Immunology and Allergy, Ankara, Turkey","institution_ids":["https://openalex.org/I149218525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032811404","display_name":"\u015eebnem Ataman","orcid":"https://orcid.org/0000-0003-3570-3825","observed_orcids":["https://orcid.org/0000-0003-3570-3825"]},"institutions":[{"id":"https://openalex.org/I149218525","display_name":"Ankara University","ror":"https://ror.org/01wntqw50","country_code":"TR","type":"education","lineage":["https://openalex.org/I149218525"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"\u015e. Ataman","raw_affiliation_strings":["Ankara University, School of Medicine, Department of PM&R, Division of Rheumatology, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ankara University, School of Medicine, Department of PM&R, Division of Rheumatology, Ankara, Turkey","institution_ids":["https://openalex.org/I149218525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004279303","display_name":"Lora Georgieva Bankova","orcid":"https://orcid.org/0000-0003-1141-1529","observed_orcids":["https://orcid.org/0000-0003-1141-1529"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Bankova","raw_affiliation_strings":["Harvard Medical School, Adverse Drug Reaction and Desensitization Program, Allergy and Immunology Training Program, Brigham and Women's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Adverse Drug Reaction and Desensitization Program, Allergy and Immunology Training Program, Brigham and Women's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109815243","display_name":"Mariana C. Castells","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Castells","raw_affiliation_strings":["Harvard Medical School, Adverse Drug Reaction and Desensitization Program, Allergy and Immunology Training Program, Brigham and Women's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Adverse Drug Reaction and Desensitization Program, Allergy and Immunology Training Program, Brigham and Women's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5054370889"],"corresponding_institution_ids":["https://openalex.org/I149218525"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":1.4121,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.78537813,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"41","issue":"3","first_page":"204","last_page":"206"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10634","display_name":"Food Allergy and Anaphylaxis Research","score":0.014999999664723873,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.949999988079071},{"id":"https://openalex.org/keywords/skin-testing","display_name":"skin testing","score":0.6880000233650208},{"id":"https://openalex.org/keywords/rapid-desensitization","display_name":"rapid desensitization","score":0.9359999895095825},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.9129999876022339},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9039999842643738},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9300000071525574},{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":1.0},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9779999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9007131457328796},{"id":"https://openalex.org/C2779779143","wikidata":"https://www.wikidata.org/wiki/Q3493547","display_name":"Desensitization (medicine)","level":3,"score":0.7902955412864685},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7591193914413452},{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.5643395185470581},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.5462923645973206},{"id":"https://openalex.org/C2994436531","wikidata":"https://www.wikidata.org/wiki/Q949302","display_name":"Skin reaction","level":2,"score":0.5441991686820984},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5159224271774292},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5136899352073669},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4822995662689209},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.4220256209373474},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.34042268991470337},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3157821297645569},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.18784555792808533},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18531200289726257},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.0952455997467041},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.06413412094116211},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05939766764640808}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D003888","descriptor_name":"Desensitization, Immunologic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004155","descriptor_name":"Diphenhydramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004890","descriptor_name":"Erythema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007428","descriptor_name":"Intradermal Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D012882","descriptor_name":"Skin Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015738","descriptor_name":"Famotidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.aller.2012.04.006","doi":"https://doi.org/10.1016/j.aller.2012.04.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.aller.2012.04.006","pdf_url":null,"source":{"id":"https://openalex.org/S4210205432","display_name":"Allergologia et Immunopathologia","issn_l":"0301-0546","issn":["0301-0546","1578-1267"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","latindex","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergologia et Immunopathologia","raw_type":"journal-article"},{"id":"pmid:23063342","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23063342","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergologia et immunopathologia","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1016/j.aller.2012.04.006","doi":"https://doi.org/10.1016/j.aller.2012.04.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.aller.2012.04.006","pdf_url":null,"source":{"id":"https://openalex.org/S4210205432","display_name":"Allergologia et Immunopathologia","issn_l":"0301-0546","issn":["0301-0546","1578-1267"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","latindex","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergologia et Immunopathologia","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1487880507","https://openalex.org/W1582918125","https://openalex.org/W1963853389","https://openalex.org/W2026544302","https://openalex.org/W2063445802","https://openalex.org/W2130494734","https://openalex.org/W2142242772","https://openalex.org/W2162254515","https://openalex.org/W2319957449","https://openalex.org/W2410784829"],"related_works":["https://openalex.org/W2737511729","https://openalex.org/W2059697159","https://openalex.org/W2026544302","https://openalex.org/W2017905221","https://openalex.org/W2751961512","https://openalex.org/W2941541702","https://openalex.org/W202049557","https://openalex.org/W593493995","https://openalex.org/W4206695107","https://openalex.org/W2791685657"],"abstract_inverted_index":{"As":[0],"the":[1,91,117,127],"number":[2],"of":[3,12,26,30,44,48,96,116,121,129,139],"monoclonal":[4,58,100,122,140],"antibodies":[5],"in":[6,88,135],"clinical":[7],"use":[8,25],"increases,":[9],"our":[10],"understanding":[11],"hypersensitivity":[13,105,142],"and":[14,39,53,63,75,93,106,111,119,132,137],"other":[15,82],"adverse":[16,61,97],"reactions":[17,32,98],"to":[18,57,99],"these":[19,31],"agents":[20],"becomes":[21],"more":[22],"intricate.":[23],"The":[24],"a":[27],"classification":[28],"scheme":[29],"can":[33],"help":[34],"elucidate":[35],"possible":[36,94],"underlying":[37],"mechanisms":[38,95],"offer":[40],"insights":[41],"into":[42],"management":[43],"reactions,":[45,62],"including":[46],"consideration":[47],"future":[49],"administrations.":[50],"Book":[51],"chapters":[52],"journal":[54],"articles":[55],"relevant":[56],"antibody":[59,123,141],"production,":[60],"desensitization":[64,134],"were":[65,78],"reviewed":[66],"without":[67],"restrictions":[68],"on":[69,104],"publication":[70],"date.":[71],"Selected":[72],"case":[73],"reports":[74],"meeting":[76],"abstracts":[77],"included":[79],"if":[80],"no":[81],"evidence":[83],"was":[84],"available.":[85],"We":[86,125],"examine":[87],"this":[89],"chapter":[90],"manifestations":[92],"antibodies,":[101],"with":[102],"emphasis":[103],"infusion":[107],"reactions.":[108,124,143],"Rituximab,":[109],"omalizumab,":[110],"cetuximab":[112],"provide":[113],"specific":[114],"illustrations":[115],"complexities":[118],"heterogeneity":[120],"consider":[126],"role":[128],"skin":[130],"testing":[131],"rapid":[133],"diagnosis":[136],"treatment":[138]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}